LexaGene detects a slow-growing bacterium at least 36-times faster than conventional methods with the potential to increase vaccine safety and supply
10. Juni 2021 07:45 ET
|
LexaGene Holdings Inc
MiQLab detects 100% of C. acnes samples 36-times faster than a culture started from ideal laboratory conditions (in 2 hours versus 3 days)MiQLab can be as much as 168-times faster than a culture...
LexaGene Sells a MiQLab System to Denver Animal Emergency
07. Juni 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., June 07, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Partners with Ethos Discovery to Develop New Companion Animal Diagnostic Tests
03. Juni 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Takes Steps to List on the Nasdaq
01. Juni 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., June 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Expands its Sales Team
11. Mai 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Hosts a Seminar to Present MiQLab Data from Veterinary Samples
14. April 2021 07:50 ET
|
LexaGene Holdings Inc
MiQLab is sensitive enough to detect the vast majority of clinical infections caused by target organisms~100% positive percent agreement with culture data on processed canine urine samples~99%...
LexaGene’s Provides Corporate Update
01. April 2021 07:50 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Receives $3.6M from the Exercise of Warrants
02. März 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene Announces Change in Management and Appoints New Member to the Board of Directors
12. Februar 2021 07:56 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene’s MiQLab Successfully Detects Mutant UK and South African COVID-19 Sequences
10. Februar 2021 08:24 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...